FAGONE, PAOLO FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 7.304
EU - Europa 3.656
AS - Asia 3.415
SA - Sud America 682
AF - Africa 667
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 15.735
Nazione #
US - Stati Uniti d'America 7.085
SG - Singapore 1.664
RU - Federazione Russa 1.137
IT - Italia 1.040
CN - Cina 946
BR - Brasile 580
IE - Irlanda 435
CI - Costa d'Avorio 304
UA - Ucraina 283
VN - Vietnam 282
FR - Francia 178
DE - Germania 163
KR - Corea 157
SN - Senegal 156
CA - Canada 155
GB - Regno Unito 99
NG - Nigeria 94
IN - India 68
SE - Svezia 68
NL - Olanda 50
AR - Argentina 43
FI - Finlandia 42
MX - Messico 41
BD - Bangladesh 34
HK - Hong Kong 34
JP - Giappone 34
ZA - Sudafrica 30
PL - Polonia 29
IQ - Iraq 27
ES - Italia 21
IR - Iran 21
BE - Belgio 20
KE - Kenya 20
UZ - Uzbekistan 20
TR - Turchia 19
EC - Ecuador 18
BJ - Benin 16
MA - Marocco 14
CH - Svizzera 13
LT - Lituania 13
PK - Pakistan 13
VE - Venezuela 13
ID - Indonesia 12
AT - Austria 11
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
BG - Bulgaria 8
CO - Colombia 8
TN - Tunisia 8
PH - Filippine 7
EG - Egitto 6
GR - Grecia 6
LB - Libano 6
TT - Trinidad e Tobago 6
AU - Australia 5
BH - Bahrain 5
BY - Bielorussia 5
ET - Etiopia 5
EU - Europa 5
GE - Georgia 5
HU - Ungheria 5
MY - Malesia 5
PE - Perù 5
PY - Paraguay 5
RO - Romania 5
UY - Uruguay 5
AO - Angola 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
JM - Giamaica 4
MK - Macedonia 4
NP - Nepal 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CL - Cile 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
TH - Thailandia 3
BO - Bolivia 2
BS - Bahamas 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BF - Burkina Faso 1
DK - Danimarca 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
Totale 15.722
Città #
Dallas 1.944
Singapore 976
Santa Clara 805
Moscow 537
Chandler 464
Dublin 434
San Jose 434
Ashburn 328
Jacksonville 306
Abidjan 304
Chicago 291
Catania 244
Hefei 220
Houston 212
Boardman 202
Beijing 164
Dakar 156
Seoul 154
Lauterbourg 126
Los Angeles 119
Cambridge 117
Lawrence 117
Andover 112
Council Bluffs 107
Ho Chi Minh City 91
Nanjing 90
New York 89
Toronto 83
Civitanova Marche 82
Des Moines 65
Palermo 62
Hanoi 59
São Paulo 54
San Mateo 51
Wilmington 48
Rome 46
Abuja 45
Grafing 45
Lagos 43
Amsterdam 42
Buffalo 36
Dong Ket 36
Lappeenranta 32
Saint Petersburg 32
The Dalles 32
Tokyo 32
Columbus 31
Hong Kong 29
Nanchang 29
Orem 29
Ottawa 28
London 27
Munich 26
Denver 25
Montreal 25
Rio de Janeiro 25
Jiaxing 24
Johannesburg 24
Boston 23
Hebei 23
Nizza di Sicilia 23
Brooklyn 22
Messina 22
Vercelli 21
Washington 21
Atlanta 20
Brussels 20
Warsaw 20
Paris 19
Tianjin 19
Bremen 18
San Francisco 18
Sant'Antonio Abate 18
Stockholm 17
Acireale 16
Augusta 16
Cotonou 16
Phoenix 16
Baghdad 15
Changsha 15
Milan 15
Shenyang 13
Ardabil 12
Chennai 12
Frankfurt am Main 12
Guangzhou 12
Leawood 12
Da Nang 11
Mexico City 11
Poplar 11
Belo Horizonte 10
Bronte 10
Campinas 10
Curitiba 10
Dearborn 10
Mascalucia 10
Amman 9
Dhaka 9
Jakarta 9
Licata 9
Totale 11.025
Nome #
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets 280
Advances in targeting signal transduction pathways. 244
Differential modulation and prognostic values of immune-escape genes in uveal melanoma 239
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 217
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 214
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 205
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 197
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 194
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 181
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 178
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets 176
Characterization of the pathophysiological role of CD47 in uveal melanoma 171
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 168
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 167
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 160
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 159
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 154
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 153
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 153
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease 152
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 149
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 148
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 147
Emerging therapeutic targets for the treatment of hepatic fibrosis 146
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 146
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. 146
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 145
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets 144
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 142
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 141
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 138
Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology 137
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 136
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L 134
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 134
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 134
Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. 131
Modulation of heat shock proteins during macrophage differentiation. 131
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 130
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 129
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 129
). NO-hybridized protease inhibitors as a new class of anticancer compounds. Saquinavir-NO as prototypical example?. 128
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 124
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 123
mTOR as a multifunctional therapeutic target in HIV infection 122
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 121
Cathepsin A levels in CD4+ T cells from HIV-positive patients 121
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 120
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 119
Comprehensive analysis of rna-seq gene expression profiling of brain transcriptomes reveals novel genes, regulators, and pathways in autism spectrum disorder 116
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus 116
Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis 115
Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study 113
In silico and in vivo analysis of IL37 in multiple sclerosis reveals its probable homeostatic role on the clinical activity, disability, and treatment with fingolimod 113
Immunoexpression and localization of heme-oxygenase-1 and MIF in lung exposed to asbestos-like fibers: an in vivo study 111
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 110
Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-β secretion by antigen-specific CD8 T cells 107
CAN THE IMMUNOMODULATORY POTENTIAL OF CARBON-OXIDERELEASING MOLECULES BE TRANSLATED INTO THE CLINICAL SETTING AS A NOVEL THERAPEUTIC OPTION FOR THE TREATMENT OF AUTOIMMUNE DISEASES? 107
Meta-analysis of transcriptomic data of dorsolateral prefrontal cortex and of peripheral blood mononuclear cells identifies altered pathways in Schizophrenia 107
The dichotomic role of macrophage migration inhibitory factor in neurodegeneration 106
Overexpression of macrophage migration inhibitory factor and its homologue d-dopachrome tautomerase as negative prognostic factor in neuroblastoma 106
Synaptic pruning genes networks in Alzheimer’s disease: correlations with neuropathology and cognitive decline 104
Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis 101
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 101
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway 99
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 99
Therapeutic potential of carbon monoxide in multiple sclerosis 97
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 96
Vitamin D3 inhibits TNFα-induced latent HIV reactivation in J-LAT cells. 95
Characterization of a small molecule modulator of inflammatory cytokine production 94
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 94
Immune modifying capacity of new melanoma therapeutics with the potency to increase efficacy of Adoptive T-cell Therapy – potential synergism of combinations 93
Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression 93
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 92
Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND 91
Therapeutic potential of nitric oxide-modified drugs in colon cancer cells 91
No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells/MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI NA DOKSORUBICIN 91
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy 90
Modulation of tetraspanin 32 (TSPAN32) expression in T cell-mediated immune responses and in multiple sclerosis 90
The cytokine network in the pathogenesis of major depressive disorder. Close to translation? 90
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review) 90
New melanoma therapeutics to improve adoptive T cell therapy - potential synergism of combinations 89
Overexpression of macrophage migration inhibitory factor and functionally‑related genes, D‑DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma 89
Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis 89
A DNA vaccine against Chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates 89
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 88
Naturally occurring compounds in differentiation based therapy of cancer. 88
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy 87
The immunobiology of apotransferrin in type 1 diabetes 87
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 87
Transcriptomic analysis reveals involvement of the macrophage migration inhibitory factor gene network in duchenne muscular dystrophy 87
Effects of combined admistration of imatinib and sorafenib in a murine model of liver fibrosis 87
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 86
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 86
Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents 86
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 85
Role of NGAL (Lcn2) in prostate cancer invasion 85
Effects of Synthetic Anti-Inflammatory Sterol in CB3V-Induced Myocarditis: A Morphological Study on Heart Muscle Tissue 85
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 85
NO-hybridized protease inhibitors as novel drugs for the treatment of cancer and autoimmune diseases 84
Totale 12.524
Categoria #
all - tutte 52.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021195 0 0 0 0 0 0 0 0 0 0 144 51
2021/2022865 76 119 4 19 143 21 126 33 65 3 20 236
2022/20231.587 124 82 29 127 145 246 18 347 350 27 48 44
2023/2024793 47 105 46 60 37 243 8 44 4 23 90 86
2024/20253.266 40 502 200 146 769 323 151 111 243 280 293 208
2025/20267.764 492 1.330 1.219 483 977 1.320 720 186 430 442 165 0
Totale 15.984